Sterol imbalances and cholesterol‐24‐hydroxylase dysregulation is linked to the underlying progression of multiple sclerosis
Brain Pathology · 2025
DOI: 10.1111/bpa.70001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Pathology, 2025. Verfasst von Lauren Griffiths und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Life Sciences 1, Faculty of Medicine, Health and Life Sciences, Swansea University, Swansea, UK. Hauptthemen laut MEDLINE: Cholesterol 24-Hydroxylase, Multiple Sclerosis, Sterols, Steroid Hydroxylases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council Impact Acceleration Account, BRAIN Unit Infrastructure Award, Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
Disability worsening in multiple sclerosis (MS) is linked to neurodegeneration. Cholesterol homeostasis is essential for normal brain function. CYP46A1, crucial for brain cholesterol turnover and reduced in some neurodegenerative diseases, is a potential neuroprotective target. We hypothesized that CYP46A1 is downregulated in MS brains and linked to cholesterol dysbalance. Mass spectrometric analysis of sterols was performed from matched plasma and cerebrospinal fluid (CSF) in an all‐female MS cohort ( n = 32, mean age = 33). Disability status was recorded at baseline and follow‐up. MS brain tissue samples ( n = 11; 7 females; ages 38–67; 10 Secondary Progressive MS, 1 Primary Progressive MS; Disease Duration: 13–49 years) and control samples ( n = 8; 3 females; ages 41–68) analysed for pathological regions using mass spectrometry and RNA expression using in‐situ hybridization. Significant dysregulation in 25‐hydroxycholesterol, 27‐hydroxycholesterol and 3β‐hydroxycholestenoic acid in CSF correlated with disability at baseline and follow‐up in the patient population. In brain tissue, reduced cholesterol, 24S‐hydroxycholesterol and 24S,25‐epoxycholesterol were observed in white matter lesions ( p < 0.05), linked to CYP46A1 activity. CYP46A1 expression was enriched in neurons, with reductions in MS grey matter lesions and non‐lesions compared to controls ( p < 0.01). Cholesterol metabolism is dysregulated in MS and is associated with reduced neuron‐specific CYP46A1 expression. Modulating CYP46A1, a druggable target, may benefit progressive MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Life Sciences 1, Faculty of Medicine, Health and Life Sciences, Swansea University, Swansea, UK.
- Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
- Helen Durham Unit, University Hospital of Wales, Cardiff, UK.
ORCID-Profile: Lauren Griffiths, Samantha Loveless, Owain W Howell
Förderung
- Medical Research Council Impact Acceleration Account
- BRAIN Unit Infrastructure Award
- Biotechnology and Biological Sciences Research Council
- Multiple Sclerosis Society
Zitieren
APA
Griffiths, L., Hawkins, K., Yutuc, E., Angelini, R., Fosuah, R., Pacciarini, M., Dickson, A., Robertson, N., Childs, L., Loveless, S., Tallantyre, E., Griffiths, W. J., Wang, Y., & Howell, O. W. (2025). Sterol imbalances and cholesterol‐24‐hydroxylase dysregulation is linked to the underlying progression of multiple sclerosis. Brain Pathology. https://doi.org/10.1111/bpa.70001
Vancouver
Griffiths L, Hawkins K, Yutuc E, Angelini R, Fosuah R, Pacciarini M, et al. Sterol imbalances and cholesterol‐24‐hydroxylase dysregulation is linked to the underlying progression of multiple sclerosis. Brain Pathology. 2025. doi:10.1111/bpa.70001
BibTeX
@article{Griffiths2025,
author = {Griffiths, Lauren and Hawkins, Kristen and Yutuc, Eylan and Angelini, Roberto and Fosuah, Racheal and Pacciarini, Manuela and Dickson, Alison and Robertson, Neil and Childs, Laura and Loveless, Samantha and Tallantyre, Emma and Griffiths, William J and Wang, Yuqin and Howell, Owain W},
title = {Sterol imbalances and cholesterol‐24‐hydroxylase dysregulation is linked to the underlying progression of multiple sclerosis},
journal = {Brain Pathology},
year = {2025},
doi = {10.1111/bpa.70001}
}
EUVIMED